Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Tablet
Product Images NDC 42858-721

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate (NDC 42858-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

This is a prescription drug with NDC code 42858-721-01. It is a combination of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. It is available in the form of tablets with a pack size of 100. It contains a medication guide that should be given to each patient. The recommended dosage of the drug can be found in the package insert.*

FDA Label Image

Principal Display Panel (7.5 mg Tablet Bottle Label)

This is a description for a medication with the NDC code 42858-722-01. The medication is a mixed salt of a single-entity amphetamine product containing Dextroamphetamine sulfate, Amphetamine sulfate, Dextroamphetamine saccharate, Amphetamine aspartate. The package includes 100 tablets and has a safety seal that should not be broken. It is advised to keep this medication out of children's reach at a temperature range of 20°C to 25°C. The package insert should be referred to for complete dosage instructions, and a medication guide accompanies each patient.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

This is a description of a medication called "Saccharate, Amphetamine Aspariate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets", which is a mixed salt single-entity amphetamine product. The usual dosage information is included in the package insert. The medication should be kept out of the reach of children, and stored at a temperature range of 20°C to 25°C. There is also a note for pharmacists to dispense the accompanying medication guide to each patient.*

FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle Label)

This is a medication called Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets. It comes in a light-resistant container and should be stored between 20°C to 25°C. The medication is a Mixed Salts of a Single-Entity Amphetamine Product and the recommended dosage is on the package insert. The pharmacist should dispense the medication guide to every patient. If the printed safety seal is missing, do not use the medication. Keep this medication away from children.*

FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

This is a description of a medication with the NDC code 42858-726-01. The medication is a tablet that contains a mix of salts of a single-entity amphetamine product, including dextroamphetamine saccharate, amphetamine aspartate, dextroumphetamine sulfate, and amphetamine sulfate. The medication guide must be dispensed to each patient by the pharmacist, and it is important to keep medication out of reach of children. The usual dosage information can be found in the package closure. There is also a warning to not use the medication if the printed safety seal is broken or missing.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

This is a description of a medication with the NDC code 42858-727-01. It contains a mixed salts of a single-entity amphetamine product including Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. The medication is available in tablet form and it should be stored at room temperature. A pharmacist should dispense it along with an accompanying medication guide to each patient. The medication should be kept out of reach of children and should not be used if the printed safety seal under the cap is broken or missing. The usual dosage information can be found in the package insert. The medication comes with a child-resistant closure as required by the USP.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.